HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
South Korea
· Delayed Price · Currency is KRW 8,310.00
-540.00 (-6.10%)
Apr 2, 2025, 3:30 PM KST
HLB Therapeutics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -22,793 | -2,302 | -11,354 | -17,197 | -16,902 | Upgrade
|
| Depreciation & Amortization | 8,092 | 8,479 | 1,666 | 1,701 | 700.54 | Upgrade
|
| Loss (Gain) From Sale of Assets | 17.69 | -4.04 | 598.18 | 14.8 | -4.18 | Upgrade
|
| Asset Writedown & Restructuring Costs | 8,037 | 131.7 | 424.08 | 4,632 | 1,953 | Upgrade
|
| Loss (Gain) From Sale of Investments | 11,678 | -9,898 | 4.14 | 10.25 | -13.53 | Upgrade
|
| Loss (Gain) on Equity Investments | 433.03 | 1,406 | -1,883 | 349.23 | 909.06 | Upgrade
|
| Stock-Based Compensation | 813.12 | 213.52 | -83.89 | 153.28 | 471.17 | Upgrade
|
| Provision & Write-off of Bad Debts | 342.66 | -277.22 | -543.03 | -301.32 | 1,239 | Upgrade
|
| Other Operating Activities | -3,475 | 1,496 | 5,645 | 470.42 | 2,899 | Upgrade
|
| Change in Accounts Receivable | 762.96 | -1,135 | 1,355 | -1,659 | 2,876 | Upgrade
|
| Change in Inventory | 773.08 | 1,356 | -2,910 | 891.62 | 74 | Upgrade
|
| Change in Accounts Payable | -3,366 | 951.82 | 605.91 | -1,605 | -6,459 | Upgrade
|
| Change in Other Net Operating Assets | -28.79 | 2,909 | -2,332 | 1,273 | 605.53 | Upgrade
|
| Operating Cash Flow | 1,288 | 3,327 | -8,809 | -11,268 | -11,651 | Upgrade
|
| Operating Cash Flow Growth | -61.29% | - | - | - | - | Upgrade
|
| Capital Expenditures | -636.97 | -301.76 | -3,396 | -822.87 | -85.54 | Upgrade
|
| Sale of Property, Plant & Equipment | 46.06 | 2,596 | 216.25 | 40.91 | 66.45 | Upgrade
|
| Cash Acquisitions | - | - | -3,008 | - | - | Upgrade
|
| Divestitures | - | 5,915 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -8,099 | -5,458 | -2,192 | -3,110 | -7,984 | Upgrade
|
| Investment in Securities | -26,740 | -24,133 | -30,370 | 18,872 | -9,793 | Upgrade
|
| Other Investing Activities | -27.32 | 1,220 | -3,409 | -697.5 | -5.78 | Upgrade
|
| Investing Cash Flow | -35,457 | -20,160 | -41,930 | 14,353 | -17,580 | Upgrade
|
| Long-Term Debt Issued | 26,000 | - | - | 65,000 | 6,332 | Upgrade
|
| Total Debt Issued | 26,000 | - | - | 65,000 | 6,332 | Upgrade
|
| Short-Term Debt Repaid | - | -3,118 | -755 | - | - | Upgrade
|
| Long-Term Debt Repaid | -7,114 | -15,096 | -2,556 | -22,146 | -6,399 | Upgrade
|
| Total Debt Repaid | -7,114 | -18,214 | -3,311 | -22,146 | -6,399 | Upgrade
|
| Net Debt Issued (Repaid) | 18,886 | -18,214 | -3,311 | 42,854 | -67.01 | Upgrade
|
| Issuance of Common Stock | 10,160 | 13,018 | - | 40,000 | 34.58 | Upgrade
|
| Repurchase of Common Stock | -636.17 | -70.12 | - | - | - | Upgrade
|
| Other Financing Activities | -15.69 | -14.59 | -7.08 | -0 | - | Upgrade
|
| Financing Cash Flow | 28,394 | -5,281 | -3,318 | 82,854 | -32.43 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.3 | 1.6 | 4.98 | 3.85 | -4.3 | Upgrade
|
| Net Cash Flow | -5,775 | -22,112 | -54,052 | 85,943 | -29,268 | Upgrade
|
| Free Cash Flow | 650.79 | 3,025 | -12,204 | -12,091 | -11,736 | Upgrade
|
| Free Cash Flow Growth | -78.49% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 1.19% | 5.75% | -28.78% | -27.74% | -27.34% | Upgrade
|
| Free Cash Flow Per Share | 7.86 | 38.84 | -179.37 | -196.99 | -205.09 | Upgrade
|
| Cash Interest Paid | 100 | - | -28.3 | 1,261 | 664.71 | Upgrade
|
| Cash Income Tax Paid | 174.67 | -33.08 | 127.17 | 40.68 | -44.97 | Upgrade
|
| Levered Free Cash Flow | -9,511 | 7,272 | -14,458 | -12,654 | -18,101 | Upgrade
|
| Unlevered Free Cash Flow | -8,283 | 7,967 | -11,241 | -11,929 | -15,442 | Upgrade
|
| Change in Net Working Capital | 3,688 | -10,577 | 2,544 | 2,920 | 1,502 | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.